-
Adults vs children, what is the difference in early warning indicators of critical COVID
Time of Update: 2023-02-02
👇 Download the decision assistant App, the guide is free at any time ~ References: [1] "Diagnosis and Treatment Plan for Novel Coronavirus Infection (Trial Tenth Edition)" ▼▼▼Click to read the original article to download the AppFor medical professionals onlyFor more guidelines for the diagnosis and treatment of common diseases in the emergency department, go to the "Clinical Decision Assistant App"!
-
New Review: Research Status and Future Development of Precision Medicine in Type 2 Diabetes
Time of Update: 2023-01-04
On November 1, 2022, The Lancet published an authoritative review "Type 2 diabetes" online, Professor Ehtasham from the Diabetes Research Center of the University of Leicester and the NIHR Biomedical Research Center of Leicester focused on the current new therapeutic targets of type 2 diabetes, described the research status and future development of precision medicine in type 2 diabetes, and took us to understand the treatment and management of type 2 diabetes from a new perspective.
-
【Cancer Cell】New! The Weill Cornell team identified potential treatments for metastatic colon cancer
Time of Update: 2022-12-30
This article is the original of Translational Medicine Network, please indicate the source for reprintingWritten by SophiaMesenchymal colorectal cancer (mCRC) is microsatellite-stable (MSS), highly connective tissue hyperplasia, CD8 T cells are excluded from the peristromal periphery, resistant to immunotherapy, and driven by low levels of atypical protein kinase Cs (aPKC) in the intestinal epithelium.
-
Conrad Biopharma announced that a key clinical trial in China of CBP-201 for the treatment of moderate to severe atopic dermatitis successfully met the primary endpoint and all key secondary endpoints
Time of Update: 2022-10-20
About this clinical trial The China pivotal clinical trial of CBP-201 for the treatment of moderate to severe atopic dermatitis (NCT05017480) is an ongoing multicenter, randomized, double-blind, parallel-group, placebo-controlled trial whose primary purpose is to evaluate the efficacy and safety of the drug, and the study will be divided into two phases.
-
Read | new drug options for anti-epileptic seizures
Time of Update: 2022-10-20
▌ Focal seizuresThe PERMIT study showed a significant reduction in monthly seizure frequency (P 104 weeks) addition of perampanel does not aggravate absence and myoclonic seizures, and that both 50 percent and 75 percent of response rates are stable during long-term treatment [9] (Figure 2).
-
A case of IgG anti-Lea antibody detected
Time of Update: 2022-08-19
In order to ensure the safety of clinical blood transfusion, for patients with Lewis blood group antibodies, cross-matching blood tests should be carried out with saline, polybrene, and column agglutination methods.
-
The results of the selection of the top ten research progress in China's hematology in 2021 were announced at the 2nd China Hematology Development Conference
Time of Update: 2022-01-24
This study revealed a new mechanism for the maintenance of hematopoietic stem cell function, and laid a theoretical foundation for in-depth exploration of the epitranscriptional regulation mechanism of blood ecology under physiological and pathological conditions .
-
ARD: Impaired fertility in men diagnosed with inflammatory arthritis: results of a large multicenter study (iFAME-Fertility
Time of Update: 2022-01-08
To analyze statistical IA influence on fertility, according to the diagnosis of age at the time of the patient groups: ≤ diagnosis 30 years old (pre-peak child-bearing age), 31-40 years of age (peak period) and ≥ 41 years of age (post-peak) .
-
Radiology: Parsonage-Turner syndrome after COVID-19 vaccine
Time of Update: 2021-12-25
Parsonage-Turner syndrome (PTS; neuropathic muscular atrophy) is a rare peripheral neuropathy characterized by sudden onset of severe upper arm pain followed by muscle weakness .
1–2 Peripheral neuropathy was reported after the new coronary pneumonia vaccination, but only 3 cases described PT, and none included relevant imaging findings .
-
Mol Neurobiol: The hypoglycemic effect of electroacupuncture ST25 through the neuromodulation of the pancreatic intrinsic nervous system
Time of Update: 2021-12-03
Xu Tiancheng, Yu Zhi, Liu Yun, et al (2021) Hypoglycemic Effect of Electroacupuncture at ST25 Through Neural Regulation of the Pancreatic Intrinsic Nervous System Mol Neurobiol doi:.
-
Frontiers in Immunology: Validation of GWAS-identified variants in response to anti-TNF drugs in rheumatoid arthritis: a meta-analysis of two large cohorts
Time of Update: 2021-12-02
Results: including 2067 Ming RA discovery cohort including patients and DREAM analysis showed that meta-registry, LINC02549 rs7767069 SNP and DAS28 between a lower overall improvement in the presence of association remained significant after multiple testing correction difference (each Allele OR Meta =0.
-
Winbond Health's wholly-owned subsidiary methylprednisolone sodium succinate for injection passed the consistency evaluation
Time of Update: 2021-11-16
On October 26, Winbond Health issued an announcement stating that its wholly-owned subsidiary Winbond Pharmaceuticals had recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration for injection of methylprednisolone sodium succinate.
-
BMJ Sub-Journal: Toxoplasma gondii has become a new hope for tumor treatment
Time of Update: 2021-11-13
Studies have shown that in mouse models of melanoma, lung cancer and colon adenocarcinoma, modified Toxoplasma gondii and anti-PD-L1 can significantly prolong the survival time of mice and inhibit tumor growth .
-
Transl Oncol: Metformin-salicylic acid treatment can improve prostate cancer treatment
Time of Update: 2021-09-29
Diabetic metforminRecently, researchers from Canada published an article in "Transl Oncol", investigating whether MET+SAL treatment can enhance PrCa tumor suppression and improve the response to RT .
Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses .
-
The Titanium Dioxide Industry Council and South Korea's Titanium Dioxide Anti-dumping Investigation Response Summary Conference was held at the same time
Time of Update: 2021-08-09
On December 30, 2015, the Korea Trade Commission issued an announcement stating that it decided to The rutile titanium dioxide imported from China initiated an anti-dumping investigation .
